Assistant Researcher (Assistant Professor) at the University of Hawaii Cancer Center, Honolulu, USA.
Dr. Geng-Xian Shi is an Assistant Researcher (Assistant Professor) at the University of Hawaii Cancer Center, Honolulu, Hawaii. Dr. Shi received his Ph.D. degree in molecular immunology from Peking Union Medical College, Beijing, China, and had postdoctoral training at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), and University of Kentucky. He has more than 60 publications in a variety of international peer-reviewed journals, books and conference proceedings. Dr. Shi?s professional interest is in the area of cancer biology, mainly focusing on the receptor tyrosine kinase (RTK)/Ras-mediated signaling that regulates tumor invasion and metastasis.
Dr. Shi research studies the role of diverse genes that regulate tumor cell migration, invasion and metastasis. His studies focus on the signaling mechanisms contributing to RTK/Ras family of small GTPases mediated endothelial barrier function and tumor invasion. The genes of interest include a mitochondrial protein, Bcl-2 inhibitor of transcription (Bit1), PEA-15, R-Ras GTPase, Rit subfamily of GTPases, Rho family of GTPases and serine/threonine kinases of p90 ribosomal S6 kinases (RSKs).
Global Experts in the subject
Amar B. Singh
Dr. Rajeev Kapoor